Stocks and InvestingStocks and Investing
Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024

Elliot Wilbur Maintained (ANIP) at Buy with Increased Target to $83 on, Sep 18th, 2024


Published on 2024-10-28 14:19:32 - WOPRAI, Elliot Wilbur
  Print publication without navigation


Elliot Wilbur of Raymond James, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Buy with Increased Target from $81 to $83 on, Sep 18th, 2024.

Elliot has made no other calls on ANIP in the last 4 months.



There are 2 other peers that have a rating on ANIP. Out of the 2 peers that are also analyzing ANIP, 1 agrees with Elliot's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Fraser of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $60 on, Wednesday, September 11th, 2024


This is the rating of the analyst that currently disagrees with Elliot


  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $94 on, Tuesday, September 17th, 2024